HDFC Securities maintains a 'Buy' rating on Apollo Hospitals and increases the target price to Rs 8,650.
Apollo Hospitals anticipates its NewCo to evolve into India's largest omni channel pharmacy and digital health platform, leading to significant synergies.
HDFC Securities foresees robust growth opportunities in various segments of Apollo Hospitals including hospitals, Healthco, and Apollo Health and Lifestyle.